Ameriprise Financial Inc. Sells 15,591 Shares of Inari Medical, Inc. (NASDAQ:NARI)

Ameriprise Financial Inc. reduced its stake in Inari Medical, Inc. (NASDAQ:NARI) by 8.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 169,906 shares of the company’s stock after selling 15,591 shares during the period. Ameriprise Financial Inc. owned approximately 0.29% of Inari Medical worth $8,674,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Sei Investments Co. grew its stake in shares of Inari Medical by 1.3% in the 4th quarter. Sei Investments Co. now owns 57,566 shares of the company’s stock worth $2,939,000 after buying an additional 727 shares in the last quarter. Barclays PLC grew its stake in shares of Inari Medical by 9.7% in the 3rd quarter. Barclays PLC now owns 288,079 shares of the company’s stock worth $11,881,000 after buying an additional 25,365 shares in the last quarter. Legato Capital Management LLC purchased a new position in shares of Inari Medical in the 4th quarter worth $681,000. Asset Management One Co. Ltd. grew its stake in shares of Inari Medical by 7.8% in the 4th quarter. Asset Management One Co. Ltd. now owns 66,149 shares of the company’s stock worth $3,504,000 after buying an additional 4,795 shares in the last quarter. Finally, AMI Asset Management Corp purchased a new position in shares of Inari Medical in the 4th quarter worth $1,651,000. 90.98% of the stock is currently owned by institutional investors.

Inari Medical Price Performance

Shares of NASDAQ:NARI opened at $79.97 on Wednesday. Inari Medical, Inc. has a 52 week low of $39.76 and a 52 week high of $79.99. The stock has a market capitalization of $4.68 billion, a P/E ratio of -59.24 and a beta of 1.02. The firm has a fifty day simple moving average of $79.97 and a two-hundred day simple moving average of $71.15.

Inari Medical Profile

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.